News
Filter
-
New £30 million translational partnership will accelerate development of new treatments for people with dementia
-
Promising new asthma medicine ready to enter early clinical trials
-
Pandemic Science Hub to develop better drugs to fight lung disease
-
Action Medical Research and LifeArc announce a fourth round of funding to support translational research into children’s rare diseases
-
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
-
Accelerating progress against dementia
-
Learning from translational research success stories during the COVID-19 pandemic
-
Hackathon brings scientists together to tackle brain health
-
LifeArc and Scottish Government work together to drive Scottish research into rare diseases
-
Covid-19 hub shortlisted for Scottish award
-
Study reveals gene faults underpinning severe COVID-19
-
Living with genetic sight loss – a family story
